Skip to main content

French Informatics Company IT.OMICS Licenses Data Miner to Galderna

NEW YORK, Oct. 19 (GenomeWeb News) - Bioinformatics company IT.OMICS has given French-Swiss drug maker Galderma access to its LSGraph data-mining technology.

 

LSGraph enables researchers to mine the functional relationships between all known genes, proteins, and chemical compounds in the scientific literature.

 

Galderma is the fifth drug maker to license the technology in the past six months. The other four were Aventis, UCB Pharma, Proskelia, and Genfit.

 

Financial terms of the agreement were not disclosed.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.